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We investigated whether dietary nitrate (NO3−) supple-
mentation enhances the effect of training in hypoxia on
endurance performance at sea level. Twenty-two healthy
male volunteers performed high-intensity endurance
training on a cycle ergometer (6 weeks, 5×30 min/week at
4–6 mmol/L blood lactate) in normobaric hypoxia (12.5%
FiO2), while ingesting either beetroot juice [0.07 mmol
NO3−/kg body weight (bw)/day; BR, n = 11] or a control
drink (CON, n = 11). During the pretest and the posttest,
the subjects performed a 30-min simulated time trial
(TT) and an incremental VO2max test. Furthermore, a
biopsy was taken from m. vastus lateralis before and after
the TT. Power output during the training sessions in both
groups increased by ∼6% from week 1 to week 6
(P < 0.05). Compared with the pretest, VO2max in the
posttest was increased (P < 0.05) in CON (5%) and BR
(9%). Power output corresponding with the 4 mmol/L
blood lactate threshold, as well as mean power output
during TT increased by ∼16% in both groups (P < 0.05).
Muscle phospho-AMP-activated protein kinase, hypoxia
inducible factor-1α mRNA content, and glycogen break-
down during the TT were similar between the groups in
both the pretest and the posttest. In conclusion, low-dose
dietary NO3− supplementation does not enhance the
effects of intermittent hypoxic training on endurance
exercise performance at sea level.
Altitude training is a popular ingredient in the training
plan of endurance athletes preparing for sea-level com-
petition. Different protocols for altitude training have
been developed. However, “living high – training low”
remains to be the most popular model because beneficial
physiological effects of altitude exposure are obtained
while maintaining normal training intensity during sea-
level training sessions (Millet et al., 2010). The develop-
ment of hypoxicators allowing to create home-based
spaces in normobaric hypoxia for either rest or training,
has added novel degrees of freedom to develop variable
altitude training protocols to beneficially impact on sea-
level performance. In this regard, over the last 10–15
years, interest in the potential of intermittent hypoxic
training (IHT), while living at sea level, on functional
performance in normoxia, has grown. Most studies have
shown beneficial physiological adaptations in skeletal
muscle due to IHT, including increased capillary and
mitochondrial density and elevated glycolytic and oxi-
dative enzyme expression (Geiser et al., 2001; Vogt
et al., 2001; Zoll et al., 2006; Hoppeler et al., 2008). We
recently also reported a 6-week period of intermittent
sprint training in hypoxia to elevate muscle phospho-
fructokinase activity compared with similar training in
normoxia (Puype et al., 2013). Nonetheless, while IHT
seems to induce favorable myocellular adaptations, the
effects on functional capacity, measured as either VO2max
or endurance performance at sea level, are equivocal
(Hoppeler et al., 2008; Bonetti & Hopkins, 2009; Millet
et al., 2010).
There is also evidence to indicate that nitric oxide
(NO) is implicated in human adaptation to hypoxia
(Levett et al., 2011; Limberg et al., 2011). NO is a ubiq-
uitous signaling molecule playing an important role in a
wide variety of physiological processes in different
tissues in the human body, including skeletal muscle
(Stamler & Meissner, 2001). Literature data indicate that
enhanced NO production may be an important factor
in human adaptation to altitude. Accordingly, well-
acclimatized Tibetan highlanders exhibit elevated circu-
lating plasma nitrite (NO2−) levels, which conceivably
reflects an upregulation of NO synthase (NOS) activity
(Erzurum et al., 2007a). Besides this endogenous
pathway, NO can also be derived via the sequential
reduction of dietary nitrate (NO3−) to NO2−, and further to
NO. Furthermore, recent studies have demonstrated that
oral NO3− intake, either as pure sodium NO3− or in the
form of beetroot juice (BR), enhanced endurance exer-
cise performance (Lansley et al., 2011a; Bond et al.,
2012; Cermak et al., 2012) or exercise capacity (Bailey
et al., 2009, 2010; Vanhatalo et al., 2010, 2011; Lansley
et al., 2011b; Masschelein et al., 2012) in young
healthy volunteers. This ergogenic effect is at least
partly explained by improved mitochondrial oxygen
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(O2) efficiency (Larsen et al., 2011, 2012). O2 efficiency
is particularly important in any condition that is associ-
ated with limited O2 availability, such as exercise at
altitude. Moreover, increased NO-mediated vasodilation
and muscle blood flow (Maiorana et al., 2003; Erzurum
et al., 2007b; Umbrello et al., 2013) by facilitating
myocellular O2 extraction, may also play a role in
improving exercise performance in hypoxia. Interest-
ingly, studies in our and other laboratories found lower
rate of O2 consumption for a given rate of submaximal
exercise (Masschelein et al., 2012; Muggeridge et al.,
2014), as well as improved exercise tolerance (Vanhatalo
et al., 2011; Masschelein et al., 2012) in hypoxia due to
NO3− intake.
Against this background, it is reasonable to postulate
that dietary NO3− supplementation may be a useful
strategy to facilitate physiological adaptations to
exercise training in hypoxia. Therefore, in this study, we
compared the effects of 6 weeks of intermittent
high-intensity endurance training in hypoxia, alone or in
conjunction with dietary NO3− supplementation, on
maximal exercise capacity and endurance exercise per-
formance at sea level.
Methods
Subjects
Twenty-two healthy, male subjects, aged 18–30 years volunteered
to take part in the study, which was approved by the KU Leuven
Ethics Committee. Subjects gave their written informed consents
after they were informed of all experimental procedures and risks
associated with the experiments, and underwent a medical screen-
ing. Exclusion criteria for participation were smoking, recent
exposure to hypoxia, and risk factors that could compromise the
subject’s safety during the study. Subjects were asked to continue
their normal sports and other physical activities throughout the
study, and they were instructed to refrain from heavy exercise,
alcohol, and caffeine-containing drinks for 48 h prior to the
experimental sessions. Furthermore, they received a list of NO3−-
rich foods to be avoided during the entire study period, aiming to
reduce involuntary daily NO3− intake. Subjects were also
instructed to refrain from using antibacterial mouthwash products,
which would inhibit the conversion of NO3− to NO2− by bacteria in
the oral cavity (Govoni et al., 2008).
Experimental protocol
Study design and experimental groups
A randomized controlled study was performed. Subjects partici-
pated in a 6-week training program consisting of high-intensity
endurance training, with a pretest before and a posttest following
the intervention. One week before the pretest, a venous blood
sample (10 mL) was taken from an arm vein into lithium heparin
tubes (BD Vacutainer, Franklin Lakes, New Jersey, USA). Plasma
was immediately separated by centrifugation (2700 g for 10 min at
4 °C) and frozen at −80 °C for later analysis of [NO3−]. The sub-
jects also performed an incremental VO2max test (60 W + 20 W/
min) on a bicycle ergometer (Avantronic Cyclus 2, Leipzig,
Germany). Subsequently, they were randomly assigned to either of
two experimental groups with similar distributions for age, body
weight (bw), and VO2max (Table 1). Both groups were enrolled in a
supervised endurance training program for 6 weeks. However, one
group received a control drink during this period (CON, n = 11),
while the other group received beetroot juice (BR; n = 11). Fol-
lowing the randomization, the subjects participated in two famil-
iarization sessions with a 24-h interval. In each session, they
performed a 30-min simulated time trial (TT) on the cycle ergom-
eter. Mean power output registered in the latter session was used as
the initial workload for the 30-min TT performed during both the
pretest and the posttest (see later). Four days before the pretest, the
subjects started the supplementation of either NO3− (0.07 mmol/kg
bw/day) in the form of BR (700 mg NO3−/L), or an equivalent
volume of apple–blackcurrant juice (Pajottenlander, Pepingen,
Belgium), which served as a control drink. The protein, carbohy-
drate, fiber, and vitamin content of the control drink was compa-
rable to BR, yet containing negligible amounts of NO3−. The daily
dose was distributed over three equal aliquots to be ingested with
breakfast, lunch, and dinner, respectively. However, during the
pretest and the posttest, the full daily dose of either BR
(0.07 mmol NO3−/kg bw, ∼500 mL) or the control drink was
administered between 2.5 and 2 h before the experimental session
(TT) started. This supplementation was continued till the end of
the posttest, which was identical to the pretest. The subjects were
not informed of the exact composition of the juices and they were
blinded to the true experimental hypotheses till the end of the
study.
Training intervention
The subjects trained in a normobaric hypoxic facility at 12.5%
FiO2, corresponding to ∼4000-m altitude. The training protocol
was adapted from Vogt et al. (2001). Subjects participated for 6
weeks in five supervised training sessions per week on a bicycle
ergometer. Blood lactate during the 30-min training sessions was
measured at 10-min intervals, and whenever needed, workload
was immediately adjusted to obtain steady-state blood lactate con-
centrations between 4 and 6 mmol/L (Vogt et al., 2001) while
cycling at cadences between 80 and 100 rpm. Each session started
with a 9-min warming up (3 min at 70%, 3 min at 80%, and
eventually 3 min at 90% of the training workload). The sessions
ended with a 10-min cooling down at 50 W. During each session,
heart rate was continuously registered (Polar, Kempele, Finland),
and a capillary blood sample (5 μL) was collected from the earlobe
at 10 and 20 min for control of blood lactate concentration
(Lactate Pro, Arkray, Japan).
Pretest and posttest
The pretest and the posttest each involved two experimental ses-
sions interspersed by a 2-day rest interval. On the evening before
each test day, the subjects received a standardized dinner
(1000 kcal: 60E% carbohydrates, 27E% fat, 13E% protein). In the
first experimental session, the subjects reported to the laboratory
between 7:00 and 10:30 h after a 10- to 12-h overnight fast. On
arrival, they received a standardized carbohydrate-rich breakfast
(710 kcal: 84E% carbohydrates, 7E% fat, 9E% protein) together
Table 1. Subject characteristics
CON BR
Age (yr) 21.4 ± 0.8 21.7 ± 0.6
Weight (kg) 72.0 ± 2.7 72.3 ± 4
VO2max (mL/min/kg) 60.8 ± 1.8 60.1 ± 2.7
Values are means ± SEM. Subjects were enrolled in a 6-week training
program in hypoxia (12.5% Fi02) while receiving either NO3− supplemen-
tation in the form of beetroot juice (BR, n = 11) or a control drink
(CON, n = 11).
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with BR (0.07 mmol NO3−/kg bw) or CON. After a ∼2-h rest, a
venous blood sample (10 mL) was taken from an arm vein into
lithium heparin tubes. Furthermore, a percutaneous needle biopsy
was taken from the left m. vastus lateralis under local anesthetic
(2–3 mL lidocaine, subcutaneously) through an incision in the
skin. Following the biopsy, the subjects started the 30-min TT
session on the cycle ergometer. After a 10-min warming up (5 min
at 100 W plus 5 min at 150 W) the TT was started (t0–t5) at
198 ± 4 W, which is the individual workload obtained from the
second familiarization session. From t5 to t25, subjects could adjust
the workload at 5-min intervals according to their subjective per-
ception of fatigue. From t25 to t30, 1-min adjustments were allowed
so as to reach a point of full exhaustion at the end of the TT.
Because workload was set identical between the pretest and the
posttest from t0 to t5, values measured in this time window were
not further considered in the statistical analyses (see later). At t0,
t20, and t30, a 5-μL blood sample was taken from the earlobe for
lactate determination. Arterial O2 saturation (%SpO2) was mea-
sured by pulsoxymetry using a sensor just above the left eyebrow
(Nellcor N-600-x, Oxismart, Mallinckrodt, St. Louis, Missouri,
USA). Furthermore, heart rate and power output were continu-
ously measured but were hidden to the subjects. At the end of the
TT, a second muscle biopsy was taken through the same incision
as the preexercise biopsy. Two days later, the subjects returned to
the laboratory between 7:00 and 10:30 h after a 10- to 12-h over-
night fast to perform a VO2max test. Initial workload was set at
60 W and was increased by 35 W/3 min until volitional exhaustion
or failure to maintain cadence > 65 rpm. During the test heart rate,
%SpO2 and pulmonary gas exchange parameters (Cortex®
Metalyzer II, Leipzig, Germany) were continuously measured and
blood (5 μL) was sampled from the earlobe for lactate assay at the
end of each stage. Following the 6-week intervention period, sub-
jects abstained from training for 3 days, where after they partici-
pated in the posttest, which was identical to the pretest and on the
same days of the week. The BR and CON were supplied till the
last day of the posttest.
Analysis of blood and muscle samples
Plasma nitrate
Blood sampling for NO3− assay was only included in a later stage of
the study, yielding a reduced number of observations (CON, n = 7;
BR, n = 6). Following sampling, the plasma was immediately sepa-
rated by centrifugation and stored at −80 °C for later analysis
of [NO3−] by a fluorometric assay using 2,3-diaminonaphthalene
(Nussler et al., 2006).
Muscle biochemistry
Part of the muscle samples was immediately frozen in liquid
nitrogen and stored at −80 °C till later analysis. Muscle glycogen
content was measured as glucose residues after acid hydrolysis
using a standard enzymatic fluorometric assay (Lowry &
Passoneau, 1972).
Western blotting
Frozen muscle tissue (∼20 mg) was homogenized 3 × 5 s with a
Polytron mixer in ice-cold buffer (1:10, w/v) [50-mM Tris-HCl
pH 7.0, 270-mM sucrose, 5-mM EGTA, 1-mM EDTA, 1-mM
sodium orthovanadate, 50-mM glycerophosphate, 5-mM sodium
pyrophosphate, 50-mM sodium fluoride, 1-mM DTT, 0.1%
Triton-X 100, and a complete protease inhibitor tablet (Roche
Applied Science, Vilvoorde, Belgium)]. Homogenates were then
centrifuged at 10 000 g for 10 min at 4 °C. The supernatant was
collected and immediately stored at −80 °C. The protein concen-
tration was measured using the DC protein assay kit (Bio-Rad
Laboratories, Nazareth, Belgium). Thirty to eighty micrograms of
proteins were separated by SDS-PAGE (10% gel) and transferred
to PVDF membranes. Subsequently, membranes were blocked
with 5% nonfat milk for 1 h and afterwards incubated overnight
(4 °C) with the following antibodies (1:1000, Cell Signaling,
Leiden, The Netherlands): phospho-AMP-activated protein kinase
(AMPK) and total AMPK. Horseradish peroxidase-conjugated
antirabbit secondary antibody (1:5000) (Sigma-Aldrich, Bornem,
Belgium) was used for chemiluminescent detection of the pro-
teins. Membranes were scanned and quantified with Genesnap and
Genetools Softwares (Syngene, Cambridge, UK), respectively
(Deldicque et al., 2010). Results were expressed relative to a stan-
dard sample that was run together with the samples to allow
comparisons between membranes, and phospho-AMPK data are
reported relative to AMPK total. All values were divided by the
mean value of the first biopsy sample (pretest) from the respective
condition.
RNA extraction, reverse transcription and real-time
qPCR analysis
Total RNA was extracted using TRIzol (Invitrogen, Vilvoorde,
Belgium) from 20 to 25 mg of frozen muscle tissue. RNA quality
and quantity were assessed by spectrophotometry with a Nano-
drop (Thermo Scientific, Erembodegem, Belgium). One micro-
gram of RNA was reverse transcribed using the High Capacity
cDNA Reverse Transcription Kit (Applied Biosystems, Gent,
Belgium) according to manufacturer’s instructions. A SYBR
Green-based Master Mix (Applied Biosystems) was used for real-
time polymerase chain reaction (PCR) analyses using the ABI
PRISM 7300 (Applied Biosystems). Real-time PCR primers were
designed for hypoxia inducible factor-1α (HIF-1α; primer
sequence: forward, GCC CCA GAT TCA GGA TCA GA; reverse
TGG GAC TAT TAG GCT CAG GTG AAC). Thermal cycling
conditions consisted of 40 three-step cycles including denaturation
of 30 s at 95 °C, annealing of 30 s at 58 °C, and extension of 30 s
at 72 °C. All reactions were performed in triplicate. To compensate
for variations in input RNA amounts and efficiency of reverse
transcription, ribosomal protein L4 (RPL4), RPL19, and beta-2-
microglobulin (β-2-MG) mRNA were quantified and results were
normalized to these values. These genes were chosen out of five
normalization genes using the GeNorm applet according to
the guidelines and theoretical framework described
elsewhere (Vandesompele et al., 2002). All values were divided by
the mean value of the first biopsy sample (pretest) from the respec-
tive condition.
Statistical analyses
The effect of the intervention was evaluated using repeated-
measures analysis of variance (ANOVA). Two-way ANOVA was
performed to compare the effects of the training in hypoxia in the
absence or presence of daily NO3− intake (CON vs BR). A planned
contrast analysis was used for post hoc comparisons when appro-
priate. Contrast analysis was also used to evaluate specific
preplanned comparisons. Also, the 95% confidence intervals
[mean ± 1.96 × standard error of mean (SEM)] of the relative
change in performance parameters were calculated. A probability
level (P) ≤ 0.05 was considered statistically significant. All data
are expressed as means ± SEM.
Results
Training intensity (Table 2)
Mean power output, heart rate, and blood lactate were
similar between CON and BR throughout the training
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period. Mean power outputs during training increased by
∼6% in both groups from week 1 to week 6 (P < 0.05).
TT performance (Table 3)
In the pretest, there were no significant differences
between the groups either for mean power output, or for
heart rate or blood lactate concentration during the TT.
However, %SpO2 was slightly higher in BR than in CON
(P < 0.05). From the pretest to the posttest, mean power
output during the TT increased to the same extent
(∼17%) in CON and BR (P < 0.05). Also, %SpO2, heart
rates, as well as blood lactate levels in the posttest, were
similar between the groups.
Incremental exercise test (Table 4)
Irrespective of the experimental condition, the training
intervention increased time to exhaustion from ∼22.5 min
in the pretest to ∼25.5 min in the posttest [P < 0.05 vs
pretest; non-significant (n.s.) between groups]. VO2max
increased by ∼5% in CON vs ∼9% in BR (P < 0.05 vs
pretest; n.s. between groups). Peak heart rates were
similar between the pretest and the posttest, yet were
slightly lower in BR than in CON (P < 0.05). Further-
more, blood lactate and respiratory exchange ratio at peak
exercise were similar between the pretest and the posttest
in both groups, yet in BR, peak blood lactate was slightly
lower in the posttest than in the pretest (P < 0.05). Fur-
thermore, the training increased power output at the
4-mM lactate threshold (LT4) by ∼13% in CON vs ∼16%
in BR (P < 0.05 vs pretest; n.s. between groups). Irrespec-
tive of the experimental condition, %SpO2 values at peak
exercise (data not shown) were in the range of 94–96% in
both the pretest and the posttest.
Muscle glycogen, phospho-AMPK and HIF-1α mRNA
expression (Table 5)
Muscle biopsies were taken before and immediately
after the 30-min TT in the pretest and the posttest. There
were no significant differences between the groups either
Table 2. Training intensity at the start and at the end of the training period
Week 1 Week 6
Mean power output (Watt)
CON 126 ± 6 134 ± 5*
BR 139 ± 6 147 ± 5*
Heart rate (bpm)
CON 165 ± 2 165 ± 2
BR 160 ± 2 160 ± 2
% HR max
CON 83 ± 1.0 83 ± 0.8
BR 86 ± 1.5 86 ± 1.2
Blood lactate (mmol/L)
CON 5.68 ± 0.19 5.75 ± 0.18
BR 5.59 ± 0.27 5.23 ± 0.14
*P < 0.05 vs week 1.
Values are means ± SEM. Subjects were enrolled in a 6-week training
program in hypoxia (12.5% Fi02) while receiving either NO3− supplemen-
tation in the form of beetroot juice (BR, n = 11) or a control drink (CON,
n = 11). Mean power output, heart rate (HR), and blood lactate were
measured after 20 min in the 30-min training bouts during week 1 and
week 6 of the training period. Percent HR max is expressed relative to the
corresponding maximal HR measured in the pretest (Table 4).
Table 3. Effects of beetroot juice in conjunction with high-intensity endur-
ance training in the time trial
Pretest Posttest Δ (CI)
Mean power output(Watt)
CON 203 ± 14 235 ± 14* 32 (28; 36)
BR 215 ± 8 252 ± 9* 37 (28; 45)
Mean SpO2 (%)
CON 96.6 ± 0.4 97.2 ± 0.2 0.5 (0.1; 1.0)
BR 98.1 ± 0.2† 97.8 ± 0.3 −0.2 (−0.9; 0.4)
Mean HR (bpm)
CON 182 ± 3 183 ± 4 0.7 (−5; 7)
BR 177 ± 4 176 ± 4 −0.3 (−3; 3)
% HR max
CON 92 ± 1.0 93 ± 1.6 0.9 (−2.9; 4.8)
BR 95 ± 1.4 95 ± 1.0 −0.1 (−1.6; 1.4)
Lactate at 20 min (mmol/L)
CON 6.8 ± 0.5 7.2 ± 0.6 0.4 (−0.5; 1.2)
BR 5.2 ± 0.7 5.6 ± 0.7 0.4 (−1.0; 1.8)
Lactate at 30 min (mmol/L)
CON 8.5 ± 0.6 9.5 ± 0.6 1.0 (−0.03; 2.0)
BR 8.0 ± 0.5 9.3 ± 0.5 1.3 (−0.4; 3.0)
*P < 0.05 vs pretest; †P < 0.05 vs CON.
Values are means ± SEM, except for Δs where mean and 95% confidence
intervals (CIs) are given. Subjects were enrolled in a 6-week training program
in hypoxia (12.5% Fi02) while receiving either NO3− supplementation in the
form of beetroot juice (BR, n = 11) or a control drink (CON, n = 11). In both the
pretest and the posttest, the subjects performed a 30-min simulated time trial
on a cycle ergometer. HR, heart rate; % HR max is expressed relative to the
corresponding maximal HR measured in the pretest (Table 4).
Table 4. Effects of beetroot juice in conjunction with high-intensity endur-
ance training during the incremental VO2max test
Pretest Posttest Δ (CI)
Power output at LT4 (Watt)
CON 204 ± 12 231 ± 10* 27 (16; 38)
BR 215 ± 10 249 ± 11* 34 (27; 42)
Time to exhaustion (s)
CON 1346 ± 63 1505 ± 52* 158 (128;189)
BR 1371 ± 47 1548 ± 53* 177 (136; 219)
VO2max (mL/min/kg)
CON 60.8 ± 1.8 63.8 ± 1.6* 3.0 (0.1; 5.9)
BR 60.1 ± 2.6 65.6 ± 2.1* 5.5. (3.2; 7.8)
Peak heart rate (beats/min)
CON 198 ± 2 197 ± 2 −1.3 (−4.1; 1.5)
BR 188 ± 3† 186 ± 3† −0.8 (−4.4; 2.8)
Peak blood lactate (mmol/L)
CON 12.4 ± 0.5 11.8 ± 0.4 −0.7 (−1.6; 0.3)
BR 11.9 ± 0.7 10.4 ± 0.7* −1.5 (−2.5; −0.5)
Peak RER
CON 1.12 ± 0.02 1.10 ± 0.02 −0.01 (−0.04; 0.02)
BR 1.12 ± 0.02 1.11 ± 0.02 −0.02 (−0.06; 0.02)
*P < 0.05 vs pretest; †P < 0.05 vs CON.
Values are means ± SEM, except for Δs where mean and 95% confidence
intervals (CIs) are given. Subjects were enrolled in a 6-week training
program in hypoxia (12.5% Fi02) while receiving either NO3− supplemen-
tation in the form of beetroot juice (BR, n = 11) or a control drink (CON,
n = 11). In both the pretest and the posttest, the subjects performed a
maximal incremental exercise test on a cycle ergometer. RER, respiratory
exchange ratio.
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for HIF-1α mRNA content or for the ratio phospho-
AMPK/AMPK total in either the pretest or the posttest.
Compared with the pretest, preexercise muscle glycogen
contents were increased in the posttest (P < 0.05), yet
there were no differences between the groups at any
time. Net glycogen breakdown during the TT was also
similar between the pretest and the posttest in both
groups.
Plasma nitrate (Fig. 1)
Baseline plasma NO3− concentrations were similar
between groups and were constant throughout the study
in CON. Compared with CON, the administration of
BR in the pretest increased plasma [NO3−] ∼sixfold
(P < 0.05), with no further increase in the posttest.
Discussion
The hypothesis driving this study was that dietary NO3−
supplementation could enhance the effects of IHT on
endurance exercise performance. For oral NO3−, intake
stimulates NO production on the one hand and NO con-
ceivably plays a role in adaptation to both endurance
training and hypoxia on the other hand (Kingwell et al.,
1997; Manukhina et al., 2006; Levett et al., 2011;
Limberg et al., 2011). However, against our hypothesis,
the data shown in this manuscript indicate that chronic
dietary NO3− supplementation in the form of BR adds
neither to the effects of IHT to increase VO2max nor does
it enhances power output at the anaerobic threshold or
TT performance at sea level.
We enrolled moderately trained healthy volunteers in
a 6-week high-intensity endurance training program
involving five weekly sessions of cycling training
(30 min) at a workload corresponding to 4–6 mmol/L
circulating blood lactate. Such training program in
hypoxia (∼4000 m), compared with similar training in
normoxia, was previously demonstrated to stimulate
some beneficial physiological adaptations in muscles,
yet failed to significantly enhance functional capacity at
sea level (Vogt et al., 2001). An identical training
program in the current study increased VO2max by 5–9%,
and enhanced power output at LT4 and during the
30-min TT by ∼15%.
We postulated that daily supplementation of NO3− in
the form of BR could enhance the aforementioned
effects of hypoxic training on performance during exer-
cise at sea level. In this regard, it is important to note that
we started the BR administration already 4 days before
the pretest with the express purpose of eliminating
the well-documented acute ergogenic effects of NO3−
supplementation in endurance exercise performance
(Hoon et al., 2013). Thus, NO3− intake (0.07 mmol/kg
bw) ∼2.5 h before the pretest increased plasma NO3−
Table 5. Effects of beetroot supplementation in conjunction with high-intensity endurance training on muscle biochemistry before and after a time trial
CON BR
Before After Before After
Glycogen content
Pretest 142 ± 12 73 ± 8† 156 ± 13 94 ± 13†
Posttest 185 ± 17* 103 ± 11*† 185 ± 10* 125 ± 11*†
HIF1-α mRNA
Pretest 1.00 ± 0.17 1.08 ± 0.08 1.00 ± 0.08 1.08 ± 0.15
Posttest 1.44 ± 0.08 1.02 ± 0.14 1.28 ± 0.14 0.95 ± 0.14
P-AMPK/Total AMPK
Pretest 1.00 ± 0.12 1.40 ± 0.13 1.00 ± 0.16 1.32 ± 0.18
Posttest 0.93 ± 0.13 1.27 ± 0.11 1.11 ± 0.13 1.40 ± 0.18
*P < 0.05 vs pretest; †P < 0.05 vs before.
Values are means ± SEM. Subjects were enrolled in a 6-week training program in hypoxia (12.5% Fi02) while receiving either NO3− supplementation in the
form of beetroot juice (BR, n = 11) or a control drink (CON, n = 11). In both the pretest and the posttest, a needle biopsy was taken from m. vastus lateralis
before and after a 30-min simulated time trial (TT) on a cycling ergometer. HIF1-α, hypoxia inducible factor 1-alpha; AMPK, adenosine monophosphate-
activated protein kinase. See Methods for more details.
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Fig. 1. Effect of beetroot juice on plasma nitrate concentration.
Values are means ± SEM for plasma nitrate (μM) before (basal),
after 4 days (pretest) and 8 weeks (posttest) of beetroot supple-
mentation (●) or a control drink (○). Between the pretest and
the posttest, the subjects were enrolled in a 6-week training
program in hypoxia (12.5% Fi02). See Methods for more details.
*P < 0.05 vs basal; †P < 0.05 vs CON.
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concentration ∼sixfold, which is in line with earlier
observations of Wylie et al. (Wylie et al., 2013). Further-
more, the daily extra NO3− intake during the training
period did not alter the plasma NO3− response to the
acute BR bolus in the posttest. Against this background,
differences between the pretest and posttest reflect the
effect of chronic NO3− intake in BR vs CON, which did
not receive the daily NO3− supplements. However, BR
stimulated neither the training-induced increments in
VO2max, nor enhanced the gain in power output at LT4 or
during the TT from the pretest to the posttest. In fact, for
none of the variables measured in either the TT or the
incremental VO2max test, we found a significant differ-
ence between BR and CON. This clearly indicates that in
the conditions of the current study, exogenous NO3−
supplementation failed to augment the effect of hypoxic
training to stimulate functional capacity in endurance
exercise at sea level.
Several mechanisms may explain these “negative”
observations. First, exercise training per se in healthy
individuals readily elevates NO bioavailability via in-
creased NOS enzyme expression and activity (Kingwell
et al., 1997; Kingwell, 2000; Manukhina et al., 2006).
Accordingly, Kingwell et al. (1997) nicely demonstrated
that just 4 weeks of cycling training markedly reduced
NO3− and NO2− consumption by the human forearm,
which is consistent with increased NO production
through the NOS pathway. Given the elevated capacity for
NO production via endogenous pathways due to training,
it is reasonable to assume that any additional stimulation
of NO production from exogenous NO3− may be redun-
dant. Such conclusion is corroborated by the finding that
the effect of NO3− supplementation to improve O2 effi-
ciency and performance in endurance exercise is much
more explicit in normal healthy volunteers than in highly
endurance-trained individuals (Christensen et al., 2013;
Hoon et al., 2013).
Second, an obvious way to stimulate training adapta-
tion by NO3− administration would be to enhance training
intensity by the administration of a high NO3− dose
(∼5–8 mmol bolus) 2–3 h before the start of the training
sessions. It is now well established that acute NO3− intake
can enhance O2 efficiency during exercise in hypoxia and
thereby also improve exercise tolerance (Vanhatalo et al.,
2011; Masschelein et al., 2012; Muggeridge et al., 2014).
We previously also found lower circulating blood lactate
concentration due to NO3− intake during submaximal
constant-load exercise in hypoxia (Masschelein et al.,
2012). Furthermore, it has been well documented that
NO3− supplementation reduces muscle metabolic pertur-
bation for a given submaximal exercise intensity in
hypoxia (Vanhatalo et al., 2011). However, this does not
necessarily imply that NO3− supplementation fully elimi-
nates hypoxic stress during exercise at (simulated) alti-
tude. Rather, it may permit a more efficient O2 utilization
against the face of a lower degree of hypoxic stress. As a
result, higher training workloads may be performed,
which in turn is conceivably associated with recruitment
of a higher fraction of fast-twitch motor units that are
otherwise “blind” to the hypoxic training stimulus. There-
fore, NO3− intake might be a useful strategy to enhance
training adaptations by facilitating higher training inten-
sities during IHT sessions, indeed. Nevertheless, one
should also consider the possibility that NO3−, by increas-
ing O2 efficiency, may reduce the degree of hypoxia
occuring in muscle cells during IHT, and thereby inhibits
additional training adaptations. The NO3− administration
protocol used in the current study probably was inad-
equate to stimulate performance in the training sessions.
The total daily NO3− dose was distributed over three
aliquots per day (∼1.7 mmol at breakfast, lunch, dinner),
and training sessions were scheduled between 2 and 4 h
following either breakfast or lunch. Such dosage protocol
results in too low circulating peak plasma NO2− levels to
enhance O2 efficiency during exercise (Wylie et al.,
2013), and thereby improve exercise tolerance in
hypoxia. Unfortunately, we could not measure plasma
NO2−. Earlier studies have shown that circulating plasma
[NO2−] increases between 1 and 15 days of NO3− admin-
istration at a dose of 5.2 mmol/day (Vanhatalo et al.,
2010). However, whether this finding can be extrapolated
to even longer periods of oral NO3− supplementation
remains to be established. In addition, as indicated above,
the NO3− administration protocol used was successful to
chronically increasing plasma NO3− concentration,
indeed. However, it is difficult to predict, on an individual
level, whether this increase in plasma [NO3−] was paral-
leled by elevated plasma [NO2−], which definitely is the
more direct parameter to predict NO availability and
biological activity (Dejam et al., 2004).
In the current study during the intervention period, we
administered 300–400 mg (0.07 mmol/kg bw) of
molecular NO3− per day. This intake rate is substantially
higher than the mean of ∼90 mg daily in an average
Western population and within the range of vegetarian
diets delivering up to 1500 mg of NO3− per day (Hill et al.,
1996; Hord et al., 2009; Mitek et al., 2013). Based on this
comparison, it is probably reasonable to conclude that
increasing daily NO3− intake just by intermittent NO3−
intake via meals, snacks, and drinks is not an adequate
strategy to enhance training adaptations in hypoxia.
Against the prevailing opinion to date, emerging evidence
indicates that diets rich in NO3− via fruits and vegetables
do not increase the prevalence of stomach cancer.
Furthermore, a series of recent studies have shown ben-
eficial effects of dietary NO3− intake in cardiovascular and
metabolic disease. Still, long-term high-dose NO3−
supplementation should still be approached with caution
till further scientific research on the safety of high-dose
NO3− boluses typically used by athletes has been done
(Bryan et al., 2012; Weitzberg & Lundberg, 2013).
It is well documented that AMPK probably plays an
important role in muscular metabolic and structural
adaptations to exercise training (Richter & Ruderman,
Puype et al.
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2009). Furthermore, exercise effects on muscle not only
depend on exercise intensity but also on the degree
of intramyocellular O2 desaturation (Geiser et al.,
2001;Hoppeler & Vogt, 2001). Therefore, it is believed
that activation of HIF-1 is necessary for training adapta-
tion by induction of “hypoxia-sensitive genes” such as
vascular endothelial growth factor or glycolytic
enzymes, as well as other metabolic proteins (Hoppeler
et al., 2008). The 30-min TT per se tended to increase
AMPK phosphorylation status both in the pretest and the
posttest, yet there was no difference between the experi-
mental groups at any time, either for AMPK total protein
content or for the phosphorylated fraction. By analogy,
irrespective of the experimental condition, HIF-1α
mRNA contents were similar between the pretest and the
posttest both before and after exercise. Thus, consistent
with the absence of beneficial effects on functional
capacity, NO3− intake did not alter the AMPK and
HIF-1α responses to the 6-week training period.
Because glycogen breakdown for a given rate of muscle
contractions is exaggerated by hypoxia (Parolin et al.,
2000), we decided also to assess the effect of the training
interventions on net glycogen breakdown during the TT.
Training expectedly increased basal muscle glycogen
content in both CON and BR, but exercise-induced net
glycogen breakdown was similar between groups in both
the pretest and the posttest.
In conclusion, the present study clearly demonstrates
that long-term low-dose dietary NO3− supplementation
does not enhance the effects of intermittent endurance
training in hypoxia on either the anaerobic threshold,
VO2max, or endurance exercise performance at sea level.
Perspectives
The hypothesis driving this study was that daily NO3−
supplementation could possibly enhance the effects of
hypoxic training on sea-level performance. However,
one could also argue that suppression of muscular O2
deficiency during contractions by improved O2 effi-
ciency due to NO3− intake, in fact, might inhibit
training adaptation. Yet we found similar training adap-
tations to hypoxic training, irrespective of whether the
training was done alone or in conjunction with daily
NO3− intake. Still, our data do not exclude that higher
daily doses of NO3−, probably best to be administered
as a bolus 2–3 h prior to the training sessions, or just
longer periods of NO3− intake, could still affect training
adaptations. It is recommended that such long-term
studies also address the impact of the NO3− administra-
tion protocol on primary health parameters.
Key words: Nitric oxide, altitude, high-intensity endur-
ance training, aerobic capacity.
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